Pre-close Trading Update

RNS Number : 6565V

EMIS Group PLC

17 January 2012

 



Press Release                                                                                                     17 January 2012

EMIS Group plc

("EMIS Group" or "the Group")

Pre-close Trading Update

EMIS Group plc (AIM: EMIS), the UK's leading supplier of healthcare software to GPs and a major software supplier to high street pharmacists, announces a trading update for the year ended 31 December 2011.  The Group intends to issue its 2011 annual results on 16 March 2012.

Trading for the year was in line with management's expectations with recurring revenue continuing at over 80%.

In the second half of the year, a further 207 GP practices went live with EMIS Web. At the year end there were: 360 GP live practices and 147 extended primary care organisations using EMIS Web, 1565 orders for EMIS Web and 2359 practices in the EMIS Web Familiarisation Service.

The Group continues to prepare for the accelerated roll-out of EMIS Web and, during the second half of 2011, the number of employees rose from 876 to 950. The Group also acquired an additional freehold property in North Leeds, at a cost of approximately £2 million in December 2011, providing the extra capacity to continue the Group's growth and support its investment plans.

The Group's UK market penetration remains strong with 53.1%^* of GP practices and with RX Systems, the Group's pharmacy system provider, continuing to grow its market share, principally through the ongoing roll-out of ProScript Link, and now serving 34.4%^* of high street pharmacies.

The Group continues to maintain a strong balance sheet with net cash of £7.8 million at 31 December 2011 (2010: net cash £1.7 million).

Sean Riddell, EMIS Group CEO, said:

"EMIS Group continues to trade in line with management expectations, enabling healthcare professionals to use and share patient data in a secure, time efficient and cost-effective manner.

"Through EMIS Web, the Group is making significant progress towards delivery of the strategic vision of cross-organisational healthcare systems: a vision that remains completely aligned with NHS strategy for the future. RX Systems is increasing its market share and EMIS IQ and patient.co.uk are already addressing the growing demand for secure clinical information from the NHS and patients alike. 

"The outlook for the new financial year is positive and we remain confident of the Group's strategic positioning and growth prospects."

For further information, contact:

EMIS Group plc                                                            Tel: [phone]

Sean Riddell, CEO

www.emis-online.com 

Numis Securities Limited                                             Tel: [phone]

Michael Meade/Simon Willis/James Black

MHP Communications                                           

Reg Hoare/James White/Giles Robinson                          Tel: [phone]

Notes to Editors

EMIS Group is the UK's leading supplier of software and related services to GP practices and a major supplier to high street pharmacies. 53.1%^* of GP Practices in the UK have an EMIS system. In addition, 34.4%^* of high street pharmacies have an Rx Systems application.

Group's core activities include software development, software licensing and support, hardware support and maintenance services, hardware sales, third party software sales and training services.

The Group's software includes all of the functionality specified in NHS accreditation standards for GPs, including holding the patient's cradle to grave electronic healthcare record, practice appointment booking systems and consultation and intelligent prescribing modules as well as a full range of high street pharmacy software products and related services.

EMIS Web represents the next generation of clinical software systems and the Directors believe it has the potential to transform the delivery of healthcare by enabling GPs and other healthcare practitioners to connect with each other and securely share access to a patient's cradle to grave electronic health record.

Established in 1987, EMIS Group' shares were listed on AIM under the trading symbol EMIS.L following a successful fundraising in March 2010.

(^*EMIS  data estimated based on company records showing customers installed or ordered (by contract or letter of intent) as at 31 December 2011. Rx Systems data is based on company records to 31 December 2011 and latest available data from The National Pharmaceutical Association as at March 2010)

 

END

 

 

TSTGGUQGGUPPGBQ